Need professional-grade analysis? Visit stockanalysis.com
$1.75B
24.55
3,026
2.17%
Tecan Group AG (TECN) trades on SIX Swiss Exchange in CHF. The company is classified in the Healthcare sector under the Medical Instruments & Supplies industry. The stock currently trades at CHF137.30, down 0.51% from the previous close.
Over the past year, TECN has traded between a low of CHF116.10 and a high of CHF176.30. The stock has lost 3.7% over this period. It is currently 22.1% below its 52-week high.
Tecan Group AG has a market capitalization of $1.75B, with a price-to-earnings ratio of 24.55 and a dividend yield of 2.17%.
Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments: Life Sciences Business and Partnering Business. The company offers liquid handling and automation, microplate readers and washers, software, consumables, sequencing reagents, immunoassays and antibodies, and Tecan Labwerx, an end-to-end automation solution. It also provides PARAMIT, a contract design and manufacturing service. Tecan Group AG has a strategic collaboration with NVIDIA Corporation to develop AI-enabled platform for data-driven laboratories to help discoveries and lab productivity. The company was founded in 1980 and is headquartered in Männedorf, Switzerland.
Side-by-side comparison against top Healthcare peers.